227 related articles for article (PubMed ID: 24047450)
21. Informing women with breast cancer about endocrine therapy: effects on knowledge and adherence.
Heisig SR; Shedden-Mora MC; von Blanckenburg P; Schuricht F; Rief W; Albert US; Nestoriuc Y
Psychooncology; 2015 Feb; 24(2):130-7. PubMed ID: 24953538
[TBL] [Abstract][Full Text] [Related]
22. Drug switch because of treatment-related adverse side effects in endocrine adjuvant breast cancer therapy: how often and how often does it work?
Güth U; Myrick ME; Schötzau A; Kilic N; Schmid SM
Breast Cancer Res Treat; 2011 Oct; 129(3):799-807. PubMed ID: 21750963
[TBL] [Abstract][Full Text] [Related]
23. The influence of endocrine treatments for breast cancer on health-related quality of life.
Buijs C; de Vries EG; Mourits MJ; Willemse PH
Cancer Treat Rev; 2008 Nov; 34(7):640-55. PubMed ID: 18514425
[TBL] [Abstract][Full Text] [Related]
24. Good adherence to adjuvant endocrine therapy in early breast cancer - a population-based study based on the Swedish Prescribed Drug Register.
Lundgren C; Lindman H; Rolander B; Ekholm M
Acta Oncol; 2018 Jul; 57(7):935-940. PubMed ID: 29493327
[TBL] [Abstract][Full Text] [Related]
25. A mindfulness-based intervention for breast cancer patients with cognitive impairment after chemotherapy: study protocol of a three-group randomized controlled trial.
Van der Gucht K; Melis M; Ahmadoun S; Gebruers A; Smeets A; Vandenbulcke M; Wildiers H; Neven P; Kuppens P; Raes F; Sunaert S; Deprez S
Trials; 2020 Mar; 21(1):290. PubMed ID: 32293533
[TBL] [Abstract][Full Text] [Related]
26. Side effects of adjuvant endocrine treatment in premenopausal breast cancer patients: a prospective randomized study.
Nystedt M; Berglund G; Bolund C; Fornander T; Rutqvist LE
J Clin Oncol; 2003 May; 21(9):1836-44. PubMed ID: 12721261
[TBL] [Abstract][Full Text] [Related]
27. Evidence-based approaches for the management of side-effects of adjuvant endocrine therapy in patients with breast cancer.
Franzoi MA; Agostinetto E; Perachino M; Del Mastro L; de Azambuja E; Vaz-Luis I; Partridge AH; Lambertini M
Lancet Oncol; 2021 Jul; 22(7):e303-e313. PubMed ID: 33891888
[TBL] [Abstract][Full Text] [Related]
28. Protocol of a randomized controlled trial of the fear of recurrence therapy (FORT) intervention for women with breast or gynecological cancer.
Maheu C; Lebel S; Courbasson C; Lefebvre M; Singh M; Bernstein LJ; Muraca L; Benea A; Jolicoeur L; Harris C; Ramanakumar AV; Ferguson S; Sidani S
BMC Cancer; 2016 Apr; 16():291. PubMed ID: 27112319
[TBL] [Abstract][Full Text] [Related]
29. The effects of Pythagorean Self-Awareness Intervention on breast cancer patients undergoing adjuvant therapy: A pilot randomized controlled trial.
Charalampopoulou M; Bacopoulou F; Syrigos KN; Filopoulos E; Chrousos GP; Darviri C
Breast; 2020 Feb; 49():210-218. PubMed ID: 31901782
[TBL] [Abstract][Full Text] [Related]
30. An integrative Tai Chi program for patients with breast cancer undergoing cancer therapy: study protocol for a randomized controlled feasibility study.
Liu L; Petrich S; McLaren B; Kelly L; Baxter GD
J Integr Med; 2018 Mar; 16(2):99-105. PubMed ID: 29526243
[TBL] [Abstract][Full Text] [Related]
31. Endocrine therapy adherence: a cross-sectional study of factors affecting adherence and discontinuation of therapy.
Quinn EM; Fleming C; O'Sullivan MJ
Ir J Med Sci; 2016 May; 185(2):383-92. PubMed ID: 25971465
[TBL] [Abstract][Full Text] [Related]
32. Impact of routine assessment of health-related quality of life coupled with therapeutic information on compliance with endocrine therapy in patients with non-metastatic breast cancer: protocol for a randomized controlled trial.
Mamguem Kamga A; Di Martino C; Anota A; Paget-Bailly S; Coutant C; Arveux P; Desmoulins I; Dabakuyo-Yonli TS
Trials; 2020 Jun; 21(1):527. PubMed ID: 32546198
[TBL] [Abstract][Full Text] [Related]
33. The Effects of Pharmacological and Non-Pharmacological Interventions on Symptom Management and Quality of Life among Breast Cancer Survivors Undergoing Adjuvant Endocrine Therapy: A Systematic Review.
Chan CWH; Tai D; Kwong S; Chow KM; Chan DNS; Law BMH
Int J Environ Res Public Health; 2020 Apr; 17(8):. PubMed ID: 32344759
[TBL] [Abstract][Full Text] [Related]
34. Recognition and management of treatment-related side effects for breast cancer patients receiving adjuvant endocrine therapy.
Cella D; Fallowfield LJ
Breast Cancer Res Treat; 2008 Jan; 107(2):167-80. PubMed ID: 17876703
[TBL] [Abstract][Full Text] [Related]
35. Quality of life and adjuvant tamoxifen treatment in breast cancer patients.
Boehm DU; Lebrecht A; Eckhardt T; Albrich S; Schmidt M; Siggelkow W; Kandelhardt E; Koelbl H
Eur J Cancer Care (Engl); 2009 Sep; 18(5):500-6. PubMed ID: 19490009
[TBL] [Abstract][Full Text] [Related]
36. Geographic disparities in adherence to adjuvant endocrine therapy in Appalachian women with breast cancer.
Tan X; Camacho F; Marshall VD; Donohoe J; Anderson RT; Balkrishnan R
Res Social Adm Pharm; 2017; 13(4):796-810. PubMed ID: 27641308
[TBL] [Abstract][Full Text] [Related]
37. Endocrine responsiveness and tailoring adjuvant therapy for postmenopausal lymph node-negative breast cancer: a randomized trial.
International Breast Cancer Study Group (IBCSG)
J Natl Cancer Inst; 2002 Jul; 94(14):1054-65. PubMed ID: 12122096
[TBL] [Abstract][Full Text] [Related]
38. National Institutes of Health Consensus Development Conference Statement: adjuvant therapy for breast cancer, November 1-3, 2000.
Eifel P; Axelson JA; Costa J; Crowley J; Curran WJ; Deshler A; Fulton S; Hendricks CB; Kemeny M; Kornblith AB; Louis TA; Markman M; Mayer R; Roter D
J Natl Cancer Inst; 2001 Jul; 93(13):979-89. PubMed ID: 11438563
[TBL] [Abstract][Full Text] [Related]
39. Analysis of Adjuvant Endocrine Therapy in Practice From Electronic Health Record Data of Patients With Breast Cancer.
Harrell M; Fabbri D; Levy M
JCO Clin Cancer Inform; 2017 Nov; 1():1-8. PubMed ID: 30657375
[TBL] [Abstract][Full Text] [Related]
40. The effectiveness of mindfulness-based stress reduction (MBSR) for survivors of breast cancer: study protocol for a randomized controlled trial.
Huang J; Shi L
Trials; 2016 Apr; 17(1):209. PubMed ID: 27101823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
